Stocks and Investing
Stocks and Investing
Wed, July 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $200 on, Jul 12th, 2023
Olivia Brayer of Cantor Fitzgerald, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $200 on, Jul 12th, 2023.
Olivia has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 2 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023
These are the ratings of the 5 analyists that currently disagree with Olivia
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $275 on, Wednesday, May 31st, 2023
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, May 5th, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $415 on, Thursday, April 27th, 2023
- William Pickering of "Bernstein" Initiated at Buy and Held Target at $243 on, Tuesday, March 21st, 2023
Contributing Sources